Clinical Trial Update: A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM) [Phase 1]

View source ↗

Summary

The Phase 1 trial evaluating an automated insulin delivery system for people with Type 1 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type1 Diabetes Mellitus | Phase 1 | Status: COMPLETED